Company intelligence / Profile preview

Zaphyr Pharmaceuticals

Hünenberg, Zug, Switzerland

Ownership: Private
Development stage: Other

Overview

Zaphyr Pharmaceuticals is a Swiss-based pharmaceutical company specializing in in-licensing and commercialization of FDA/European innovative products and branded generics, with an established oncology and rare disease portfolio for the Middle East and Africa region. The company leverages extensive partnerships and regulatory expertise but there are no publicly available clinical trial results as their core activity focuses on distribution and commercialization rather than drug discovery or early development. They focus on in-licensing, out-licensing, and distribution/commercialization.

Therapeutic areas: OncologyRare DiseasesOther
Modalities: Small moleculeBiologicBranded generic
Industry: Consulting

Beyond the preview

Go deeper on Zaphyr Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zaphyr Pharmaceuticals.

Explore the full profile